Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | Chief Accounting Officer | September 15, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 16,398 |
Reported balance
After 2026-09-15 transaction · row 1
1 source rowRow 1 · 2026-09-15 · Gift · Disposed 600 · Balance 16,398 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 20:16 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000014 · wk-form4_1789589777.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,398 Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 00:00 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,366 | $0.00 Strike: $86.68 | $0.00 |
DisclosureSEC source: 0002061393-26-000012 · wk-form4_1785888034.xml · derivative · entry 4 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,366 Underlying: Ordinary Shares · 1,366 shares Expires 2036-08-03 F7 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 00:00 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 2,337 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000012 · wk-form4_1785888034.xml · derivative · entry 3 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,337 Underlying: Ordinary Shares · 2,337 shares Expires not disclosed F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. F5 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. F6 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,337 shares will be issued. If maximum performance metrics are achieved, 5,609 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 00:00 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,337 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000012 · wk-form4_1785888034.xml · nonDerivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,998 F3 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. Read SEC document |
| July 31, 2026 Filed Aug 5, 2026 00:00 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 212 | $85.39 | $18,102.68 |
DisclosureSEC source: 0002061393-26-000012 · wk-form4_1785888034.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,661 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 136 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| June 05, 2026 Filed Jun 8, 2026 21:01 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 237 | $83.32 | $19,746.84 |
DisclosureSEC source: 0002061393-26-000010 · wk-form4_1780952493.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,737 F1 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on April 24, 2026. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:24 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Unit · Derivative | 1,621 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000008 · wk-form4_1779999857.xml · derivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3 · derivative.exercise_date: The performance share units vested on April 24, 2026. F3 · derivative.expiration_date: The performance share units vested on April 24, 2026. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:24 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,712 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000008 · wk-form4_1779999857.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:18 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 318 | $81.90 | $26,044.20 |
DisclosureSEC source: 0002061393-26-000006 · wk-form4_1777493911.xml · nonDerivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,262 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:18 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 1,508 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000006 · wk-form4_1777493911.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,580 F1 · shares: Represents restricted stock units that vest in three annual installments beginning one year from the date of grant. F2 · balance_after: Includes 106 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:19 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000004 · wk-form4_1771967954.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,966 Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:06 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 148 | $101.00 | $14,948.00 |
DisclosureSEC source: 0002061393-26-000002 · wk-form4_1770066410.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,306 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 97 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:17 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-25-000004 · wk-form4_1764019068.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,357 F1 · balance_after: Includes 99 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 214 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · derivative · entry 10 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 214 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Unit · Derivative | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · derivative · entry 9 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 58 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 1, 2025. F6 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Unit · Derivative | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · derivative · entry 8 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 246 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 1, 2025. F6 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 196 | $89.34 | $17,510.64 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 7 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,428 Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 214 | $78.00 | $16,692.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 6 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 204 | $89.34 | $18,225.36 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 5 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,410 F4 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 22 | $89.34 | $1,965.48 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 4 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,614 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 3 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 31, 2022 and earned dividend equivalents. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 93 | $89.34 | $8,308.62 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,578 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,278 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000110 · wk-form4_1753906508.xml · derivative · entry 3 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,278 Underlying: Ordinary Shares · 1,278 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 2,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000110 · wk-form4_1753906508.xml · derivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,202 Underlying: Performance Share Unit · 2,202 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,202 shares will be issued. If maximum performance metrics are achieved, 4,404 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000110 · wk-form4_1753906508.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,425 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 52 shares acquired through dividend reinvestment and 28 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 20:30 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000085 · wk-form4_1749069015.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,143 Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:22 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000071 · wk-form4_1746044537.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,453 F1 · shares: Represents restricted stock units that vest in three annual installments beginning one year from the date of grant. F2 · balance_after: Includes 62 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.